Monocyte activation and acquired autoimmune protein S deficiency promote disseminated intravascular coagulation in a patient with primary antiphospholipid syndrome. Issue 5 (28th June 2021)

• Record Type: Journal Article
• Authors: Beckmann, Lennart; Voigtlaender, Minna; Holstein, Katharina; Lennartz, Maximilian; Schneider, Stefan W.; Haddad, Munif; Renné, Thomas; Bokemeyer, Carsten; Rolling, Christina C.; Langer, Florian
• Is Part Of: Research and practice in thrombosis and haemostasis. Volume 5:Issue 5(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-28
• Subjects: antiphospholipid syndrome -- disseminated intravascular coagulation -- monocytes -- protein S -- tissue factor; Thrombosis -- Periodicals; Hemostasis -- Periodicals; 616.135005
• DOI: 10.1002/rth2.12559
• Languages: English
• ISSNs: 2475-0379

Abstract

Abstract: Autoimmune protein S (PS) deficiency is a highly thrombotic, potentially life‐threatening disorder. Its pathophysiological relevance in the context of primary antiphospholipid syndrome (APS) is unclear. Here, we report the case of a 76‐year‐old woman, who presented with a painful reticular skin erythema caused by microvascular thromboses. Disseminated intravascular coagulation (DIC) with consumptive coagulopathy was controlled only by continuous anticoagulation. While significantly elevated IgM antibodies to cardiolipin and β2 ‐glycoprotein‐I were consistent with primary APS, a function‐blocking PS autoantibody of the IgG isotype was detected. Robust microvesicle (MV)‐associated tissue factor (TF) procoagulant activity (PCA) was isolated from patient plasma. Moreover, patient IgG, but not IgM, induced expression of TF PCA and release of TF‐bearing MVs by peripheral blood mononuclear cells from healthy donors. In primary APS, induction of monocyte TF in combination with an acquired PS inhibitor may provoke a deleterious imbalance of procoagulant and anticoagulant pathways with evolution of thrombotic DIC.